4//SEC Filing
Dake Benjamin T 4
Accession 0001415889-24-020662
CIK 0001798749other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 6:00 PM ET
Size
13.1 KB
Accession
0001415889-24-020662
Insider Transaction Report
Form 4
Dake Benjamin T
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2024-08-01$1.74/sh+1,507$2,622→ 14,252 total - Exercise/Conversion
Common Stock
2024-07-31$1.74/sh+11,454$19,930→ 12,745 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-07-31−906→ 0 totalExercise: $1.74Exp: 2030-09-03→ Common Stock (906 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-08-01−1,507→ 0 totalExercise: $1.74Exp: 2030-09-03→ Common Stock (1,507 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-07-31−10,548→ 1,507 totalExercise: $1.74Exp: 2030-09-03→ Common Stock (10,548 underlying)
Footnotes (2)
- [F1]A total of 48,293 shares subject to an employee stock option were granted on September 4, 2020, with 10% of the shares vested on January 1, 2020, an additional 22.5% of the shares vested on January 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.
- [F2]A total of 72,325 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Aerovate Therapeutics, Inc.
CIK 0001798749
Entity typeother
Related Parties
1- filerCIK 0001869248
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 6:00 PM ET
- Size
- 13.1 KB